U.S. Physical Therapy, Inc. Expected to Earn FY2018 Earnings of $2.50 Per Share (USPH)
U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities researchers at Cantor Fitzgerald issued their FY2018 earnings estimates for shares of U.S. Physical Therapy in a research note issued on Sunday. Cantor Fitzgerald analyst J. France expects that the company will post earnings of $2.50 per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $90.00 price objective on the stock.
A number of other equities research analysts also recently weighed in on the company. Jefferies Group set a $76.00 target price on U.S. Physical Therapy and gave the company a “hold” rating in a report on Friday, February 23rd. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a report on Saturday, January 6th. Finally, Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, March 9th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $79.40.
U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, March 8th. The company reported $0.49 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.49. The firm had revenue of $109.20 million for the quarter, compared to the consensus estimate of $104.12 million. U.S. Physical Therapy had a return on equity of 13.12% and a net margin of 5.38%.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Wednesday, March 21st will be issued a dividend of $0.23 per share. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend is Tuesday, March 20th. This represents a $0.92 annualized dividend and a dividend yield of 1.11%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 45.71%.
In related news, CFO Lawrance W. Mcafee sold 2,000 shares of the firm’s stock in a transaction on Monday, March 12th. The stock was sold at an average price of $86.06, for a total transaction of $172,120.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Bernard A. Harris, Jr. sold 6,000 shares of the firm’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $86.53, for a total value of $519,180.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,625 shares of company stock worth $1,295,029. 3.10% of the stock is currently owned by company insiders.
Large investors have recently made changes to their positions in the stock. SG Americas Securities LLC bought a new position in U.S. Physical Therapy during the 3rd quarter worth $170,000. UBS Asset Management Americas Inc. bought a new position in U.S. Physical Therapy during the 4th quarter worth $206,000. Ladenburg Thalmann Financial Services Inc. raised its position in U.S. Physical Therapy by 59.9% during the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,770 shares of the company’s stock worth $231,000 after purchasing an additional 1,412 shares during the last quarter. Envestnet Asset Management Inc. raised its position in U.S. Physical Therapy by 48.6% during the 4th quarter. Envestnet Asset Management Inc. now owns 3,704 shares of the company’s stock worth $267,000 after purchasing an additional 1,212 shares during the last quarter. Finally, Crossmark Global Holdings Inc. bought a new position in U.S. Physical Therapy during the 3rd quarter worth $274,000. 96.53% of the stock is owned by institutional investors and hedge funds.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.